Who we are

Launched in March 2020, COVID-NMA is an international initiative working in conjunction with the World Health Organization (WHO), led by a team of researchers from Cochrane and other institutions (Université de Paris, Inserm, CNRS, Centre for Evidence-Based Medicine Odense (CEBMO), University of Southern Denmark, Odense University Hospital, Epistemonkos Foundation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan).

This initiative involves a broad multidisciplinary consortium.

Our Vision

Decisions on COVID-19 treatments and preventive interventions are informed through a living Evidence Ecosystem developed by an international collaborative effort.

Our missions

Our goals

Our project relies on three main pillars:

  1. Performing a living mapping of all registered trial evidence to help funders and researchers planning future trials, 
  2. Producing a living systematic review of trial evidence to support healthcare decision making 
  3. Assessing trials methodology and transparency to improve future research.

Our values and principles